Proveris Scientific – Regulatory Guidance

As a convenience to its website visitors, Proveris provides the following links to regulatory guidance documents.*

*Proveris provides the links solely as a convenience and does not control the content on or privacy policies governing access to and use of the linked websites, which are the responsibility of the entity that has published each of the linked websites.
Regulatory Guidance
Guidance for Industry
Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action, Draft Guidance
Guidance for Industry Part 11
Electronic Records; Electronic Signatures – Scope and Application
Process Validation Requirements
Drug Products and Active Pharmaceutical Ingredients Subject to Pre-Market Approval
Medicines and Healthcare products Regulatory Agency
Making Regulatory Decisions about Medicines and Medical Devices
European Medicines Agency
Guideline on the Pharmaceutical Quality of Inhalation and Nasal Products